Navigation Links
Omeros Corporation Reports Third Quarter 2012 Financial Results
Date:11/9/2012

SEATTLE, Nov. 9, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the third quarter of 2012.

Financial ResultsTotal operating expenses for the quarter ended September 30, 2012 were $14.5 million compared to $7.2 million for the same period in 2011. The increase in operating expenses primarily relates to a one-time litigation settlement payment of $3.95 million, which our insurance company has agreed to reimburse to us subject to a reservation of rights, increased Phase 3 clinical trial expenses for OMS302 and increased employee expenses, partially offset by a decrease in expenses in connection with preclinical work for other programs. Given that the $3.95 million that Omeros' insurer has agreed to reimburse had not been received by Omeros as of September 30, 2012, that amount is not included in operating expenses for the 2012 period.  For the quarter ended September 30, 2012, Omeros reported a net loss of $13.3 million, or $0.51 per share, compared to a net loss of $6.5 million, or $0.29 per share, for the same period in 2011. At September 30, 2012, Omeros had cash, cash equivalents and short-term investments of $30.6 million.  

"Now with positive results from both of our two pivotal Phase 3 clinical trials evaluating OMS302, Omeros is becoming a commercial company," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "We are working to file an NDA in the first quarter of 2013 followed by an MAA in mid-year, and we look forward to releasing data from two more clinical programs before year-end – our Phase 3 meniscectomy and our Phase 1 PDE10 programs. Our clinical pipeline is expandi
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer
2. Omeros Ophthalmology Product OMS302 Successful in Second Phase 3 Clinical Trial
3. Omeros Files Investigational New Drug Application for Lead Compound in PDE10 Program
4. Omeros to Present at Two Upcoming Conferences
5. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
6. Omeros Corporation Reports Second Quarter 2012 Financial Results
7. Omeros Announces Discovery in MASP-2 Program
8. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
9. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
10. Omeros Prices $30 Million Public Offering of Common Stock
11. Omeros Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 Dynatronics Corporation (NASDAQ: DYNT ) today ... to the Company,s Board of Directors effective March 23, 2015, ... 2014 of board member Joseph Barton .  ... Board of Directors represents an important step forward for the ... of Dynatronics.  "Rich is a proven leader and is well-known ...
(Date:3/27/2015)... 27, 2015 The Temple Health & Bioscience District ... 5,000-square-foot building at 1802 South First St. in the Temple ... the City of Temple to receive ... the Central Texas Veterans Health Care System, the new facility ... early stage biotechnology and life science companies. ...
(Date:3/27/2015)... 2015 XRpro Sciences, Inc., a provider ... development services which features high throughput transporter and ... financial results for the year ended December 31, ... of XRpro Sciences commented, "We have completed a ... stage to commercial stage in large part by ...
Breaking Medicine Technology:Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4
... 21, 2011 VIVUS, Inc. (Nasdaq: VVUS ) ... Food and Drug Administration (FDA) for the New Drug Application ... obesity.  The meeting occurred on January 19th at the FDA,s ... the FDA and VIVUS, management and consultants.  At this meeting ...
... held) today announced that they have signed a multi-year ... clear, and manufacture assays for the Abbott Molecular FDA ... terms have not been disclosed. IMDx ... evolving clinical needs. The tests are designed utilizing IMDx,s ...
Cached Medicine Technology:VIVUS Provides Regulatory Update on QNEXA NDA 2VIVUS Provides Regulatory Update on QNEXA NDA 3Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu of Molecular Tests 2
(Date:3/27/2015)... The federal court overseeing thousands of ... medication increases the risk that a patient will develop ... Dismiss four individual cases that had been filed in ... in the U.S. District Court, District of South Carolina, ... were warranted because the plaintiffs in those claims had ...
(Date:3/27/2015)... Kansas City, Mo (PRWEB) March 27, 2015 ... common complications for patients undergoing percutaneous coronary intervention ... Ironically, studies have observed a “risk-treatment paradox,” in ... to gain from treatment are treated less often ... , Researchers at Saint Luke’s Mid America Heart ...
(Date:3/27/2015)... Healthpointe is proud to announce that ... now treating knee and hip joint disorders in practice ... Beach, and La Mirada. Dr. Stanley Katz specializes in ... joint disorders as well as chronic conditions such as ... his patients back to their normal lives. Many ...
(Date:3/27/2015)... Ticket Down is a reputable source for authentic ... After a phenomenal and highly successful live tour last year, the ... on tour again in 2015 and they will be visiting 8 ... 29th in New York City at the cozy Beacon Theatre and ... May 10th. , Fans of the hit show can look forward ...
(Date:3/27/2015)... Jose, CA (PRWEB) March 27, 2015 While ... week’s 2015 GPU technology conference (GTC) , the CEO ... fight cancer and push the human lifespan well beyond the ... MD informatics company , is one of 12 companies ... , While other startups in the GTC Emerging Companies ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 3Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3
... - Investigators from the Slone Epidemiology Center at Boston University ... high in vegetables and fruit gained less weight over a ... red meat and fried foods. This is the first prospective ... less weight gain in African American women, a population with ...
... , FRIDAY, May 20 (HealthDay News) -- ,One graduation ceremony ... casual contact is not likely to increase your risk of ... total of 5,209 hands while graduating from schools across the ... disease-causing bacteria, according to research from scientists at the Johns ...
... side effect of impairing the patient,s immune system. This ... fungi, especially since bacteria, like Staphylococcus aureus , ... BioMed Central,s open access journal Annals of Clinical ... wild plants against bacterial and fungal infections in the ...
... News) -- If you,re planning on digging up your garden or ... slow, take breaks and stretch. Experts caution that jumping ... lead to back pain. "When it comes to gardening and ... long winter to become accustomed again to the physical stresses of ...
... of the body,s systems for repairing DNA damage--have lower ... such defects, according to a study published online May ... Institute. About 15% of colorectal cancers are ... by the inherited gene mutations found in Lynch syndrome ...
... intelligence agents watching for the real terrorists threatening to ... via hand-washing squads in hospitals can go a long ... diff bacteria, says Irena Kenneley, an infection prevention ... the Frances Payne Bolton School of Nursing at Case ...
Cached Medicine News:Health News:Diet high in vegetables and fruit associated with less weight gain in African-American women 2Health News:Are All Those Handshakes at Graduation Hazardous to Your Health? 2Health News:Herbal remedies offer hope as the new antibiotics 2Health News:Stretch Before You Pick Up That Rake: Expert 2Health News:DNA repair system affects colon cancer recurrence and survival 2Health News:Combating the C. diff terrorists on the loose in hospitals 2Health News:Combating the C. diff terrorists on the loose in hospitals 3
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical conventional laryngoscopes....
CCR Medical conventional laryngoscope handles....
... The Intubating LMA™ Airway. , ... or unexpected difficult airway, the LMA Fastrach™ ... without moving the head or neck. The ... attempts. , ,Selected by emergency teams ...
Medicine Products: